Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of 3,4-Dihydroxyphenylacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.54 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.54 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.54 |
| ▸ | ALOX5 known ✓ | P09917 | 1/20 | 0.48 |
| ▸ | PTGS1 known ✓ | P23219 | 3/20 | 0.47 |
| ▸ | ADORA3 known ✓ | P0DMS8 | 1/20 | 0.47 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | GAA | P10253 | 2/20 | 0.67 |
| ▸ | APEX1 | P27695 | 2/20 | 0.67 |
| ▸ | THPO | P40225 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | RGS12 | O14924 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31618868 | 0.82 | KDM4E (0.72) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL22982989 | 0.82 | KDM4E (0.72) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL10997511 | 0.82 | CA2 (0.70) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL1331519 | 0.81 | KDM4E (0.70) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL29503757 | 0.81 | KDM4E (0.70) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL36348 | 0.80 | GAA (1.00) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL29382155 | 0.80 | GAA (1.00) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| Hydrochloric Acid SCHEMBL28072109 | 0.79 | KDM4E (0.68) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL4323348 | 0.78 | KDM4E (0.67) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL2734611 | 0.78 | KDM4E (0.67) | KDM4EMAPTHIF1AHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013024028-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING PROTEINOPATHIES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2013-02-21 | — | — | WO | claimed |
| WO-2013024028-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING PROTEINOPATHIES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2013-02-21 | — | — | WO | disclosed |
| US-6015792-A | Specific eatable taste modifiers | BIORESEARCH, INC. (US) | 2000-01-18 | — | — | US | disclosed |
| US-6008250-A | Specific eatable taste modifiers | BIORESEARCH, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| US-5866608-A | AROMATIC COMPOUNDS | BIORESEARCH, INC. (US) | 1999-02-02 | — | — | US | disclosed |
| US-5703053-A | TASTELESS INGESTIBLE COMPOUNDS WHICH REDUCE OR ELIMINATE UNDESIRABLE TASTES IN EATABLES | BIORESEARCH, INC. (US) | 1997-12-30 | — | — | US | disclosed |
| US-5700792-A | Specific eatable taste modifiers | BIORESEARCH, INC. (US) | 1997-12-23 | — | — | US | disclosed |
| US-5665755-A | NAPHTHO(1,2-D)IMIDAZOLE-5-SULFONATES (TASTANDS) USED TO REDUCE BITTER OR METALLIC TASTES; FOODS, DRUGS, ARTIFICIAL SWEETENERS; POTASSIUM CHLORIDE | BIORESEARCH INC. (US) | 1997-09-09 | — | — | US | disclosed |
| US-5654311-A | TASTANDS OF PYRIMIDINE DERIVATIVES, E.G. OROTIC ACID, TO REDUCE OR ELIMINATE A BITTER OR METALLIC TASTE; FOODS; DRUGS; SWEETENERS; POTASSIUM CHLORIDE | BIORESEARCH INC. (US) | 1997-08-05 | — | — | US | disclosed |
| US-5650403-A | PURINE-BASED COMPOUNDS (TASTANDS, E.G. IOSINE, GUANOSINE AND XANTHINE-5'-PHOSPHATE) USED TO REDUCE OR ELIMINATE A BITTER OR METALLIC TASTE; FOODS; DRUGS; ARTIFICIAL SWEETENERS; POTASSIUM CHLORIDE | BIORESEARCH, INC. (US) | 1997-07-22 | — | — | US | disclosed |
| EP-0036534-B1 | AN ORALLY ADMINISTRABLE DRUG FORM COMPRISING A BETA-LACTAM ANTIBIOTIC AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1987-09-23 | — | — | EP | disclosed |
| EP-0035770-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A GLYCOSIDIC ANTIBIOTIC AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1986-12-30 | — | — | EP | disclosed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | disclosed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | disclosed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | disclosed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | disclosed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | disclosed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | disclosed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | disclosed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | disclosed |